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Abstract 
UV spectrophotometric and NIR spectroscopic methods were developed for determining 
the active ingredient (5-ethyl-2'-deoxy-uridine) in the antiviral ointment (Revidur). 
UV spectrophotometric measurements were carried out at 263 nm with solution 
of the ointment in absolute ethanol prepared by ultrasonication. Calibration solutions 
contained the matrix. The standard error of the method was 0.016%, the correlation 
coefficient of the calibration curve was 0.999 in the range 0.25 to 2.5% drug content. 
Two NIR methods are described in the present work. In one of the methods, NIR 
reflectance spectra were taken of solutions and concentration determinations were carried 
out based on the second derivative of the spectra at 1166 nm. 
The correlation coefficient was equal to that calculated for the UV method, and the 
standard calibration error was slightly higher, 0.05%. The advantage of the method is its 
quickness if calibration data are available. 
The simpler method developed seems to be suitable for the determination of the 
drug directly in the ointment without any pretreatment. In the is method, the second 
derivative of the NIR reflectance spectra measured at 2466 and 1528 nm are used. How-
ever, due to inhomogeneity problems with the calibration samples resulting in a standard 
calibration error one order of magnitude higher than that for the solution technique, we 
consider our results with the direct method to by only preliminary onesand intend to 
continue our studies. 
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Introduction and Literature Survey 
Chemical structure, formula and name of the drug: 
Cll H16N2 0 5 
U ridine, 2 - deoxy - 5 - ethyl -
(15 176 - 29 - 1) 
Edoxudine 
Structural studies of the compound by NMR and CD spectroscopy 
were published in 1973 (CLEVE, HOYER, SCHULZ G. and VERBRUEGGEW) 
and 1975 (KEMIN, 1. EKIEL, and SHUGAR). Separation from biological 
matrix by HPLC (CSARNYI, SZABOLCS, VAJDA and "OTvas 1979), ion-
pair chromatography (HEMPEL, 1982), GC (GARZE, ALEXANDER and TILL 
1980), TLC and LC (KAUL and HEMPEL, 1985) have also been dealt with 
in the literature. 
However, the determination of the drug in pharmaceutical prepara-
tions appears to have not been described yet. The preparation studied in 
the present work is an emulsion-type ointment with antiviral effect pro-
duced by REANAL (Budapest, Hungary). During manufacture, the aque-
ous solution of the drug is homogenized in the matrix. The drug content 
of the ointment is controlled by a method elaborated in the manufacturer's 
laboratory. The procedure consists of the following steps: 
1. Extraction of the organic matrix with chloroform after addition of 
water and zinc chloride. 
2. Separation of the organic and aqueous phase. 
3. Preparation of a calibration graph using aqueous solutions contain-
ing the drug in different and ZnCl2 in constant concentration after 
measuring the absorbance at 267 nm. 
4. The drug transferred in the aqueous phase is determined by means of 
the calibration graph. 
In the present work, a method has been worked out for the deter-
mination of the active principle in the ointment 'Revidur' which involves 
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no extraction step and applies calibration measurements in the presence of 
the ointment matrix to eliminate matrix effects. The composition of the 
ointment is as follows (for 10 g total weight): 
drug: 0.1 g; 
sorboxaethenum stearinicum 0.40 g, 
paraffinum liquid urn 0.40 g, 
alcohol cetylstearylicus 1.20 g, 
vaselinum album 2.00 g, 
solution conservans 0.20 g, 
aquadestillata 5.70 g. 
Determination of the Drug by UV Spectrophotometry 
Experimental Conditions and Solution 
The drug content was determined in absolute ethanol solution. By sonica-
tion saIl the components of the ointment were dissolved in absolute ethanol 
which could not have been achieved otherwise. A series of calibration so-
lutions was prepared by mixing the solution of the matrix and that of the 
drug in appropriate proportions. 
Ointment samples were dissolved in absolute ethanol by sonication. 
Absorbance measurement was carried out by a Zeiss Specord UV-VIS 
spectrophotometer. 
The solution of the matrix: 0.1 g matrix was weighed on an analytical 
balance, transferred to a 100 cm3 volumetric flask with 80 cm3 abso-
lute ethanol and sonicated for 4 min. The solution thus obtained was 
filled up to the mark with absolute ethanol. 
Sample solution was prepared similarly, using ointment portions de-
pending on the expected drug concentration (0.1 g in the case of 1 % 
and 0.08g in the case of 2.5% drug content). 
Drug stock solution 
0.05 g of the drug was dissolved in absolute ethanol similarly to the 
above solutions. 
Calibration solutions were prepared as given in Table 1. 
Results and Discussion 
The UV spectra of the solution of the matrix and of the two ointment 
samples were taken in the range of 200-300 nm and it was found that the 
matrix components did not interfere in the determination of the drug if the 
solution of the matrix was used as reference solution (Fig. I). 
The spectra of the calibration series are shown in Fig. 2. 
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Table 1 
Data of the series of calibration solutions for the determination of the drug in the 
ointment Revidur by UV spectrophotometry 
Drug stock solution, cm3 0.0.5 0.10 0.20 0.30 0.50 
Solution of the matrix, cm 3 9.9.5 9.90 9.80 9.70 9.50 
Drug concentration 
(in % of the matrix) 0.25 0.50 1.00 1.50 2 .. 50 
AA 
0.6 
0.4 
0.2 
o~~==±=~==~==~~==~~~==~ 
48 44 40 36 32 
xl0 3 cm- 1 
Fig. 1. UV spectra of the solutions of the ointment matrix and of two Revidur ointment 
samples in absolute ethanol. 1: matrix; 2: Revidur sample with 1 % drug content; 
3: Revidur sample with 2 .. 5% drug content 
five parallel series were prepared, each series consisting of five mem-
bers. 
The parameters of the equation describing the concentration depen-
dence of the absorbance measured at 263 nm, the correlation coefficient 
and the standard error of the calibration (for interpretation see the next 
chapter) were calculated: 
.'1263 nm = -0.008 + 0.351c [%], 
r = 0.999, 
standard calibration error=0.016 [%]. 
The above equation was used for determinig the drug in various prepa-
rations and the results were always close to the values expected. 
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The recovery of added drug was also studied. Some of the results are 
as follows: 
Theoretical concentration, % 
Measured concentration, % 
1.60 
1.58 
2.10 
2,08 
2.59 
2.56 
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Determination of the Drug by NIR Spectroscopy 
Determination in Absolute Ethanol Solution 
E:tperimental Conditions and Solutions 
Calibration solutions were prepared as described in Chapter 1. The drug 
content of the series members in % of the matrix were: 0.25, 0.50, 1.0, 
1.5 and 2.5. In preliminary experiments, NIR spectra of the calibration 
solutions were taken against the internal reference of the instrument. The 
latter gave better results. 
The measurements were made using a Pacific Scientific NIR instru-
ment type 6250. 
Results and Discussion 
Three spectra were taken of each calibration solution and the computer 
program of the instrument processed the second derivative of the averaged 
spectrum to find the wave length at which there is correlation between the 
spectrum or its second derivative and the concentration of the drug and to 
determine the parameters of the calibration curve, correlation coefficients 
and other statistical parameters. 
The reflectance spectrum and its second derivative for a calibration 
solution are shown in Fig. 3, the calibration curve calculated for the sec-
ond derivative at 1166 nm, with the standard deviation of the deviation 
of concentrations determined based on the calibration curve from actual 
concentrations are shown in Fig. 4. 
The value of the correlation coefficient (r) reflects a close correlation 
between optical and chemical data. 
Direct Determination from Ointments 
(Preliminary Experiments) 
The aim of our further NIR studies was to simplify the technique by elim-
inating both the extraction and dissolution, i. e. to carry out the determi-
nation directly in the ointment which is a viscous liquid. 
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Fig. 3. NIR reflectance spectrum (1) and its second derivative (2) taken of a calibration 
standard solution 
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Fig. 4. Calibration curve at 1166 nm. Standard error of calibration: 0.05%, r=0.999 
Experimental Conditions 
The preparation of the calibration series was problematic, as no ointment 
samples with different drug content were available, So we prepared calibra-
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Table 2 
Data of the calibration series for the direct determination of the drug in the ointment by 
,';IR spectroscopy 
,';0. of calibration 
sample 2 3 ., .5 
Concentration of 
the drug, % 4.0 2.0 1.0 0 .. ) 0.1 
Weight of matrix 9.6g .).Og .).Og .S.Og 4.0g 
Weight added 0.4 g .).Og .).Og .5.0g LOg 
drug ointment ointment ointment ointment 
with 4% with 2% with 1% with 0 . .5% 
drug drug drug drug 
tion samples by gradual dilution from the matrix and the active ingredient 
of the ointment with known concentrations in amounts shown in Table 2. 
The samples thus prepared were homogenized in an agate mortar. The 
concentrations of the calibration samples were controlled by the UV spec-
trophotometric method given in Chapter 2. Calibration was carried out in 
the concentration range 0.2-4%. NIR reflectance spectra and their second 
derivatives were taken as described above against the internal reference of 
the instrument. 
Results and Discussion 
The instrument processed the average from three spectra. The reflectance 
spectrum and its second derivative of a calibration sample is shown in 
Fig. 5, the calibration curve produced by the instrument based on the 
second derivatives at 2466 nm and 1528 nm in Fig. 6 and Fig. 7 respectively, 
along with the standard error and correlation coefficient. 
Using the calibration curves, some Revidur ointment samples were 
analyzed for the active ingredient under the same experimental conditions. 
The results obtained were close to those expected through determination 
by the solution method UV and NIR spectroscopy. 
The method for the direct drug determination from the ointment. 
needs further refinement, since inhomogeneity problems arose in the cali-
bration samples reflected by t.he correlation coefficient. and standard cali-
bration error values at both wavelengths. In the present paper we intended 
to publish the results of our preliminary experiment.s wit.h the direct NIR 
determination. 
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Fig. 5. NIR reflectance spectrum (1) and its second derivative (2) of an ointment cali-
bration sample 
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Fig. 6. Calibration curve for 2·166 nm. standard error of calibration: 0.50%. 1'=0.955 
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